Every year, billions of dollars are spent in the development and sale of pharmaceuticals. That’s a lot of money and with that money comes the need for legal security. Since the first days of our firm, we have been a leader in securing pharmaceutical intellectual property and we recognize that strong patent protection for pharmaceuticals drives medical progress by providing economic incentives for innovation.
The pharmaceutical practice of our firm has grown in size and scope and provides patent portfolio advice, due diligence, opinions, and patent prosecution for both brand and generic industries, as well as universities and research institutes. Additionally, we have handled inter partes proceedings for our pharmaceutical clients, including litigation, interferences and oppositions in foreign patent offices. We are also experienced in the areas of cosmetics, nutraceuticals and cosmaceuticals.
Our attorneys have expertise in Food, Drug and Cosmetic Law, particularly Abbreviated New Drug Application (ANDA) Paragraph IV opinions, and evaluating pharmaceutical patents, vis-a-vis scope, infringement and validity. In addition, we counsel clients on patent and FDA patent extension strategies.
Many of our attorneys hold doctorate degrees and apply their unique understanding of science and the law in preparing and prosecuting patent applications relating to numerous drug delivery technologies, including oral controlled release in the area of biodegradable particulate delivery systems including microspheres, polymer coating, matrix, and pellet systems, needleless syringes, and transdermal drug delivery systems.